Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$IRMD Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.55 up 17.02% YoY • Reported revenue of $24.2M up 14.15% YoY • Iradimed expects Q4 2026 revenue of $25M to $26.5M and GAAP diluted EPS of $0.53 to $0.57; FY2026 revenue of $91.6M to $93.1M and GAAP diluted EPS of $1.90 to $1.94.

Price since post

Full Details

Advertisement|Remove ads.